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Serum trlglycedde (TG) levels, a possible confounder, did not correlate 
equally with Factor VIIc activity across raca-sex groups and Factor Vllc 
remained associated with CAD after adjustment for TG. Factor VIIc activity 
may be associated with CAD, especially in African Americans and women. 
These consistent associations cannot be explained by coaasociations with 
TG, and require further study. 
4:45 
~'~' -~ Women Alter Myocardial Infarction Fare Worse Than 
Men, A 12-Year Follow-Up of 1120 Women end 3688 
Men Surviving Acute MI 
Michal Benderly, Solomon Behar, Hendefta Reicher-Reiss, Vaiontina Boyko, 
Ud Gold'oourt for the SPRINT Study Group. Neufeld Cardiac Research 
Institute, Sheba Medical Center, TeI-Hashomec Israel 
Although women have higher mortality rates than men dudng hospitaliza- 
tion for MI, confficting results have been reported regard'rag their long term 
prognosis. •We previously reported an increased mortality dsk for women 
dudng hospitalization (adjusted relative odds for women versus men: 1.72). 
An extended follow-up facilitated an analysis of 12-year mortality of 1120 
female and 3688 male MI survivors hospitalized in Israel dudng the years 
1981--83. Women discharged were older than men (66:1:9 and 60 :!: 11 
years respectively) and were more likely to exhibit co-morb~.d conditions (age 
adjusted prevalences of hypertension and diabetes were 1.4 and 1.5 times 
higher than in men). Dudng follow-up, 65% of women died compared to 520 
of men. Unadjusted (a) and adjusted (b) 12 years survival rates for women 
(dashed line) and men (solid line) are presented in the figure: 
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After Controlling for age, pre-infamtion characteristics and hospital course 
in a proportional hazard regression analysis, the risk of mortality in women 
was 20% higher then in men. Life table analysis indicated that the disadvan- 
tage of women evident in the first year following the index MI, is slit: apparent 
in the twelfth year of follow-up. 
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~ Validation and Stability of Cox Models to Predict 
Survival After Coronary Angioplasty 
William S. Weintreub, Andrzej S. KosinskL Emory University School of 
Medicine, Atlanta, Georgia 
To assess the validity of Cox model analysis to predict survival after coronary 
angioplasty, 10,785 patients were dwidnd into 7,190 training and 3,595 vail* 
dation patients. For training patients multivariate correlates of survival were 
older age, diabetes, reduced ejection fraction, congestive failure, angina 
class, hypertension (all p < 0.0001) and vessels diseased (p = 0.022). Each 
group was divided by age group in decades, < 40, 40-49, 50-59. 60--69, 
70-79, • 80, The pfeo'icted mortality in the training was compared to ob- 
served in valk/ation. The model was limited at extreme of age, < 40 and 
>_ 80 (left figure), with predicted st, v~al at times outside 95% confidence 
intervals. In the middle ranges of age, the predicted survival was largely 
within the narrower 95% confidence infenrals (right figure). 
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There was little difference in correlates between the total of 10,785 and 
the training roup of 7.190. As the population was further educed, drop out 
of covadates occurred: hypertension at 3,595, congestive failure at 2.175, 
angina class at 1,078, ejection fraction at 539 with angina class reemerging, 
and angina class and vessels diseased at 269. Distortions in hazard ratios 
increased with each step. Cox model analysis has limitations at the extremes 
of the population, and is subject o overmndeling with spurious results in 
small populations. 
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~ W h y  Do Smokers Have a Better Prognosis ~rdh 
Acute Myocardial infarction? Insights From the 
PAMI-2 Trial 
Bruce Bredie, Tern/Bowers, William O'Neill, John Griffin, Bryan Donohue, 
Constantino Constantini, C. Balestrini, Grego Stone, Denise E. Jonas, 
Cindy Grines. The Moses H. Cone Memorial Hospital, Greensboro, N.C.; 
Beaumont Hospital, Royal Oak, MI 
Thmmbotytio trials for acute myocardial infarction (AMI) have shown smokers 
have a more favorable prognosis vs. non-smokers. Adiustment for clinical 
variables has not completely explained this paradox. The PAMI-2 trial ob- 
tained acute angiographio data on AMI pts. prior to repoduaion with PTCA 
that might provide unique insight into this paradox. Current smokers had a 
lower mortality (0.8 vs. 2P, o, P = 0.04), less re-infarction (3.6 vs. 5.7%, P = 
0.20), and less recorrent ischemia (93 vs. 14%, P = 0.03). PTCA was equally 
effective in establishing TIMI 3 flow in smokers and non-smokers. There were 
strikin§ differences in baseline clinical and anglographic vafiablos between 
smokers and non-smokers. 
Current Smoker (N = 387) Non-Smoker (N= 496) P Value 
Age (yrs.) 54 4. 11 64 4.11 0.001 
Hypertension 41% 50% 0.007 
Diabetes 12% 18% 0.01 
Prior MI 10% 19% 0.001 
Prior CABG 1.3% 6.5% 0.001 
Lyric Eligible 76% 69% 0.03 
Muitiveseel CAD 31% 44% 0.001 
LVEF (%) 50.5 4- 12 48.6 4.12 0.02 
Smoking did not effect outcomes in a multivadable model that corrected 
for these clinical and angiographlc differences. 
Conclusion: Smokers present with AMI at a younger age, with fewer asceci- 
ated diseases, and less advanced coronary disease and better left ventricular 
function. Adjustment for differences in age and severity of disease completely 
explain the more benign prognosis of smokers. 
